Company Profiles

driven by the PitchBook Platform

AbSci

AbSci
2011 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Series B LATEST DEAL TYPE
$2.1M LATEST DEAL AMOUNT
7 INVESTORS
Description

Developer of cutting-edge protein production technologies designed to reduce costs in the bio-pharmaceutical industry. The company's next-generation E. coli expression platform, SoluPro achieves revolutionary yields of soluble and active protein and peptide products and in less time, expresses proteins intracellularly while avoiding appreciable formation of aggregates, enabling users to achieve reductions in the cost of producing novel and existing biologics, acceleration of drug discovery timelines and increased efficiency and flexibility throughout the manufacturing process.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
101 East 6th Street
Suite 300
Vancouver, WA 98660
United States

+1 (503) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AbSci’s full profile, request a free trial.

AbSci Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 07-Aug-2017 $2.1M 00.00 Completed Generating Revenue
4. Early Stage VC (Series A) 11-Apr-2016 00.00 00.00 0000 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2013 Completed Generating Revenue
2. Grant Completed Generating Revenue
1. Angel (individual) Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

AbSci Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Oregon Angel Fund Venture Capital Minority 000 0000 000000 0
Phoenix Venture Partners Venture Capital Minority 000 0000 000000 0
Rany Raviv Angel (individual) Minority 000 0000 000000 0
WRF Capital Venture Capital Minority 000 0000 000000 0
OTRADI Bioscience Incubator Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

AbSci Executive Team (5)

Name Title Board
Seat
Contact
Info
Sean McClain Co-Founder & Chief Executive Officer
Suzanne Sprunger Ph.D Chief Intellectual Property Officer
Mark Valasek Co-Founder & Advisor
Philip Barish Ph.D Vice President of Operations

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com